Delivery Order SPE2DB20D7059-SPE2DB25FGRY0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,033.20 to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drop solution (15ml) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $2,295.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Refresh Tears 0.5% eye drops (15ml units). This is a non-set-aside competitive award with an ultimate completion date of August 5, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,381.67 to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drop solution (15 mL) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction executed under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drops (15 mL) with a ceiling value of $1,277.84 under a firm fixed-price contract structure. This is a non-set-aside award issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under the company's...
- This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is a $2,345.55 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of 0.5% Refresh Tears eye drops in 15ml bottles. The contract has a period of performance through June 14, 2024 and was awarded on June 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Refresh Plus 0.5% eye drops in unit dose format (50 units) valued at $2,397.84. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,360.12, is for the delivery of Refresh Tears 0.5% eye drops in 15 milliliter bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of February 24, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,227.39 firm-fixed-price delivery order is for the supply of 0.5% Refresh Tears eye drops in 15 ml bottles. The contract has an ultimate completion date of September 29, 2022 and was awarded on September 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Tears 0.5% eye drops in 15 milliliter bottles. The firm-fixed-price contract has a ceiling value of $2,474.50 and a period of performance through May 21, 2025. The contract was not set aside for small businesses. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $20,829.15 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Refresh Plus 0.5% eye drops (30-count units). This is a firm fixed-price, competitively awarded contract with a completion date of September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRY0Delivery Order
The Defense Logistics Agency awarded a $1,142.15 delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for Refresh Tears 0.5% eye drop solution in 15ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 15, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical supply vendor for the Defense Logistics Agency and military healthcare systems. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. This delivery order for ophthalmic supplies exemplifies the company's role in fulfilling routine federal medical procurement requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/13/25 |